Mechanical and oral antibiotic bowel preparation versus no bowel preparation in right and left colectomy: subgroup analysis of MOBILE trial.


Journal

BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685

Informations de publication

Date de publication:
05 03 2021
Historique:
received: 21 10 2020
accepted: 15 01 2021
entrez: 11 4 2021
pubmed: 12 4 2021
medline: 23 11 2021
Statut: ppublish

Résumé

In retrospective series, mechanical and oral antibiotic bowel preparation (MOABP) has been reported to reduce surgical-site infections (SSIs) after colectomy compared with no bowel preparation (NBP). This was a subgroup analysis of a multicentre randomized trial that included patients scheduled for elective colectomy. The MOABP group underwent mechanical bowel preparation, and took 2 g neomycin and 2 g metronidazole orally during the day before surgery. The NBP group did not undergo bowel preparation. Patients were categorized according to the side of resection (right versus left colectomy), and these subgroups compared for postoperative outcomes. Among 217 patients undergoing right colectomy (106 in MOABP and 111 in NBP group), SSI was detected in seven (7 per cent) and 10 (9 per cent) patients (odds ratio (OR) 0.71, 95 per cent c.i. 0.26 to 1.95; P = 0.510), anastomotic dehiscence in two (2 per cent) and two (2 per cent) patients (OR 1.05, 0.15 to 7.58; P = 1.000), and the mean(s.d.) Comprehensive Complication Index (CCI) score was 9.4(12.9) and 10.5(18.0) (mean difference -1.09; 95 per cent c.i. -5.29 to 3.11; P = 0.608) in the MOABP and NBP groups respectively. Among 164 patients undergoing left colectomy (84 in MOABP and 80 in NBP group), SSI was detected in five (6 per cent) and eight (10 per cent) patients (OR 0.57, 0.18 to 1.82; P = 0.338), anastomotic dehiscence in four (5 per cent) and five (6 per cent) patients (OR 0.75, 0.19 to 2.90; P = 0.742), and the CCI score was 10.2(13.1) and 6.5(11.0) (mean difference 3.68, -0.06 to 7.42; P = 0.053) in the MOABP and NBP groups respectively. MOABP did not decrease the rate of SSI or complications in patients undergoing either right or left colectomy compared with NBP.

Sections du résumé

BACKGROUND
In retrospective series, mechanical and oral antibiotic bowel preparation (MOABP) has been reported to reduce surgical-site infections (SSIs) after colectomy compared with no bowel preparation (NBP).
METHOD
This was a subgroup analysis of a multicentre randomized trial that included patients scheduled for elective colectomy. The MOABP group underwent mechanical bowel preparation, and took 2 g neomycin and 2 g metronidazole orally during the day before surgery. The NBP group did not undergo bowel preparation. Patients were categorized according to the side of resection (right versus left colectomy), and these subgroups compared for postoperative outcomes.
RESULTS
Among 217 patients undergoing right colectomy (106 in MOABP and 111 in NBP group), SSI was detected in seven (7 per cent) and 10 (9 per cent) patients (odds ratio (OR) 0.71, 95 per cent c.i. 0.26 to 1.95; P = 0.510), anastomotic dehiscence in two (2 per cent) and two (2 per cent) patients (OR 1.05, 0.15 to 7.58; P = 1.000), and the mean(s.d.) Comprehensive Complication Index (CCI) score was 9.4(12.9) and 10.5(18.0) (mean difference -1.09; 95 per cent c.i. -5.29 to 3.11; P = 0.608) in the MOABP and NBP groups respectively. Among 164 patients undergoing left colectomy (84 in MOABP and 80 in NBP group), SSI was detected in five (6 per cent) and eight (10 per cent) patients (OR 0.57, 0.18 to 1.82; P = 0.338), anastomotic dehiscence in four (5 per cent) and five (6 per cent) patients (OR 0.75, 0.19 to 2.90; P = 0.742), and the CCI score was 10.2(13.1) and 6.5(11.0) (mean difference 3.68, -0.06 to 7.42; P = 0.053) in the MOABP and NBP groups respectively.
CONCLUSIONS
MOABP did not decrease the rate of SSI or complications in patients undergoing either right or left colectomy compared with NBP.

Identifiants

pubmed: 33839753
pii: 6220257
doi: 10.1093/bjsopen/zrab011
pmc: PMC8038265
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Cathartics 0
Metronidazole 140QMO216E
Neomycin I16QD7X297

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.

Références

Dis Colon Rectum. 2017 Dec;60(12):1291-1298
pubmed: 29112565
Dis Colon Rectum. 2017 Aug;60(8):761-784
pubmed: 28682962
Colorectal Dis. 2018 Nov;20(11):955-958
pubmed: 30199608
Colorectal Dis. 2018 Sep;20 Suppl 6:15-32
pubmed: 30255646
Ann Surg. 2015 Sep;262(3):416-25; discussion 423-5
pubmed: 26258310
Dis Colon Rectum. 2018 Jun;61(6):e341-e342
pubmed: 29722733
Ann Surg. 2016 Jun;263(6):1085-91
pubmed: 26756752
Ann Surg. 2015 Jun;261(6):1041-3
pubmed: 25575263
Ann Surg. 2014 Nov;260(5):757-62; discussion 762-3
pubmed: 25379846
Lancet. 2019 Sep 7;394(10201):840-848
pubmed: 31402112
Lancet. 2019 Sep 7;394(10201):808-810
pubmed: 31402111
Br J Surg. 2020 Feb;107(3):167-170
pubmed: 31872429
Ann Surg. 2015 Jun;261(6):1034-40
pubmed: 25607761
Int J Colorectal Dis. 2018 Dec;33(12):1781-1791
pubmed: 30238356
Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):708-709
pubmed: 31548712
Ann Surg. 2019 Jul;270(1):43-58
pubmed: 30570543
Ann Surg. 2015 Aug;262(2):331-7
pubmed: 26083870
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
Ann Surg. 2018 Apr;267(4):734-742
pubmed: 28151800
Dis Colon Rectum. 2016 Jan;59(1):70-78
pubmed: 26651115
Br J Surg. 2019 Mar;106(4):355-363
pubmed: 30802304
Surgery. 2018 Mar;163(3):528-534
pubmed: 29198768
Ann Surg. 2019 Apr;269(4):671-677
pubmed: 29064902
JAMA Netw Open. 2018 Oct 5;1(6):e183226
pubmed: 30646234
JAMA Surg. 2020 Jan 1;155(1):80-81
pubmed: 31693066
Perioper Med (Lond). 2017 Mar 3;6:4
pubmed: 28270910

Auteurs

L Koskenvuo (L)

Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

T Lehtonen (T)

Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

S Koskensalo (S)

Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

S Rasilainen (S)

Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

K Klintrup (K)

Department of Surgery, Surgical Research Unit, Medical Research Centre, Oulu University Hospital, University of Oulu, Oulu, Finland.

A Ehrlich (A)

Department of Surgery, Central Hospital of Central Finland, Jyväskylä, Finland.

T Pinta (T)

Department of Surgery, Seinäjoki Central Hospital, Seinäjoki, Finland.

T Scheinin (T)

Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

V Sallinen (V)

Department of Gastroenterological Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH